MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03584nam a2200421 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
44938 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
BD-DhAAL |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20251015104101.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
251015t2024 nyua b 001 0 eng d |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2023005637 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780826149329 |
| Qualifying information |
(paperback) |
|
|---|
| Cancelled/invalid ISBN |
9780826149336 |
| Qualifying information |
(eBook) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
22961459 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
DLC |
| Modifying agency |
DLC |
| -- |
BD-DhAAL |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC271.C5 |
| Item number |
C3224 2024 |
| 060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 269 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.994061 |
| Edition number |
23 |
| 999 ## - SYSTEM CONTROL NUMBERS (KOHA) |
|---|
| Koha biblionumber |
47559 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Cancer pharmacology : |
| Remainder of title |
an illustrated manual of anticancer drugs / |
| Statement of responsibility, etc |
edited by Ashkan Emadi, Judith E. Karp. |
| 246 18 - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
Cancer pharmacology |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Second edition. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
New York, NY : |
| Name of publisher, distributor, etc |
Springer Publishing Company, |
| Date of publication, distribution, etc |
c2024. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xvi, 454 pages : |
| Other physical details |
color illustrations ; |
| Dimensions |
26 cm |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Drug Development in Oncology / Edward A. Sausville and Ashkan Emadi -- Pharmacogenomics / Milly Graveno -- Critical Components of Clinical Trials Development : From Bench to Bedside and Back / S. Percy Ivy, Richard F. Little, and Joshua F. Zeidner -- Drug Development and Regulatory Considerations / Vicky Hsu, Matthew D. Thompson, Donna Przepiorka, and Olanrewaju O. Okusanya -- Alkylating Agents / Ashkan Emadi and Edward A. Sausville -- Pyrimidine- and Purine-based Antimetabolites, Hydroxyurea, Asparaginases / Ashkan Emadi and Judith E. Karp -- Antimetabolites : Antifolates / Justin Lawson -- Antimitotics / Edward A. Sausville and Ashkan Emadi -- DNA Repair, Apoptotic Pathways, and CDK Inhibitors / Mira A. Kohorst and Scott H. Kaufmann -- Epigenetic Modulators / Sergiu Pasca and Lukasz P. Gondek -- Differentiating Agents and Microenvironment / Yuya Nagai and Gabriel Ghiaur -- Targeted Therapeutics (Small Molecules) / Yuchen (Jake) Liu and Ashkan Emadi -- Hormonal Therapies Alone and in Combinations for Treatment of Breast Cancer / Amy M. Fulton and Katherine H. R. Tkaczu -- Androgen Receptor Axis Targeting in the Treatment of Prostate Cancer / Vincent C. O. Njar and Arif Hussain -- Multiple Myeloma as a Paradigm for MultiTargeted Intervention / Kathryn Maples and Sagar Lonial -- Transplant-Related Agents : Focus on Graft vs. Host Disease Prevention and Treatment / Vedran Radojcic -- Monoclonal Antibodies Including Immunoconjugates, Antibody-Drug Conjugates, and Cytokine-Directed Agents / Alison Duffy and Ciera Bernhardi -- Immunotherapeutics : Immune Checkpoint Inhibitors, Vaccines, Bispecifics, and Engineered T Cells / Mark Yarchoan and Elizabeth Jaffee. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
"We are living in an exciting time for cancer pharmacology. The fusion of multiple disciplines of basic and clinical science is creating effective, life-prolonging therapies for a growing number of malignancies. The progress is electrifying and the promise for patients is exhilarating!"-- |
| 526 ## - STUDY PROGRAM INFORMATION NOTE |
|---|
| Program name |
PHR |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Antineoplastic Agents |
| General subdivision |
pharmacology. |
| 9 (RLIN) |
59602 |
|
|---|
| Topical term or geographic name as entry element |
Neoplasms |
| General subdivision |
drug therapy. |
| 9 (RLIN) |
38333 |
|
|---|
| Topical term or geographic name as entry element |
Molecular Targeted Therapy. |
| 9 (RLIN) |
38334 |
|
|---|
| Topical term or geographic name as entry element |
Pharmacy. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Emadi, Ashkan, |
| Relator term |
editor. |
| 9 (RLIN) |
59603 |
|
|---|
| Personal name |
Karp, Judith E., |
| Relator term |
editor. |
| 9 (RLIN) |
59604 |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Display text |
Online version: |
| Title |
Cancer pharmacology |
| Edition |
Second edition. |
| Place, publisher, and date of publication |
New York, NY : Springer Publishing Company, [2024] |
| International Standard Book Number |
9780826149336 |
| Record control number |
(DLC) 2023005638 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Book |
